SLRC Stock Analysis: SLR Investment | NASDAQ
Asset Management | NASDAQ, USA | Market Cap: 690m USD | 12M Return: -15% | US83413U1007 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.71M
EPS Trend: -74.5%
Qual. Beats: 0
Rev. Trend: 34.5%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
SLR Investment Corp. is a Business Development Company (BDC) that provides debt and equity financing to leveraged middle-market companies. Its investment offerings include first-lien and second-lien secured loans, subordinated unsecured debt, and minority equity stakes, supporting leveraged buyouts, acquisitions, recapitalizations, refinancings, and growth capital transactions.
The fund maintains an exceptionally broad sector mandate, spanning roughly 50+ industries including aerospace and defense, healthcare, software, financial services, manufacturing, retail, telecommunications, energy, and consumer products. Within healthcare, it specifically targets life sciences sub-sectors such as specialty pharmaceuticals, medical devices, and biotechnology.
As a BDC, SLR Investment Corp. operates under a regulated structure that requires it to distribute most of its taxable income to shareholders, making it part of the financials sector with a focus on asset management and custody banking activities.
- Fed rate cuts compress net interest margin
- Non-accruals rise on middle market credit stress
- Net investment income fails to cover dividend distribution
| Net Income: 73.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.72 > 1.0 |
| NWC/Revenue: 754.8% < 20% (prev 27.63%; Δ 727.1% < -1%) |
| CFO/TA 0.05 > 3% & CFO 130.3m > Net Income 73.8m |
| Net Debt (-322.5m) to EBITDA (110.1m): -2.93 < 3 |
| Current Ratio: 6.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (55.0m) vs 12m ago 0.90% < -2% |
| Gross Margin: 66.05% > 18% (prev 59.12%; Δ 6.93% > 0.5%) |
| Asset Turnover: 7.00% > 50% (prev 6.53%; Δ 0.48% > 0%) |
| Interest Coverage Ratio: 1.56 > 6 (EBIT TTM 106.9m / Interest Expense TTM 68.5m) |
| A: 0.53 (Total Current Assets 1.61b - Total Current Liabilities 266.6m) / Total Assets 2.56b |
| B: -0.05 (Retained Earnings -133.5m / Total Assets 2.56b) |
| C: 0.04 (EBIT TTM 106.9m / Avg Total Assets 2.55b) |
| D: 0.62 (Book Value of Equity 982.1m / Total Liabilities 1.58b) |
| Altman-Z'' = 4.22 = AA |
As of August 23, 2026, the stock is trading at USD 12.63 with a total of 410,155 shares traded. Over the past week, the price has changed by -2.02%, over one month by -4.54%, over three months by -1.37% and over the past year by -14.99%.
Current recommended Stop Loss: 12.20 (which is 3.4% or 1.6 ATR below the current price).
SLR Investment has received a consensus analysts rating of 3.56. Therefore, it is recommended to hold SLRC.
- StrongBuy: 3
- Buy: 2
- Hold: 2
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 15 | 18.8% |
P/E Trailing = 9.3015
P/E Forward = 10.4275
P/S = 3.2932
P/B = 0.7038
P/EG = 4.3701
Revenue TTM = 178.5m USD
EBIT TTM = 106.9m USD
EBITDA TTM = 110.1m USD
Long Term Debt = 887.1m USD (estimated: total debt 1.15b - short term 266.6m)
Short Term Debt = 266.6m USD (from shortTermDebt, last quarter)
Debt = 1.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -322.5m USD (calculated: Debt 1.15b - CCE 1.48b)
Enterprise Value = 367.7m USD (690.1m + Debt 1.15b - CCE 1.48b)
Interest Coverage Ratio = 1.56 (Ebit TTM 106.9m / Interest Expense TTM 68.5m)
EV/FCF = 4.76x (Enterprise Value 367.7m / FCF TTM 77.2m)
FCF Yield = 20.99% (FCF TTM 77.2m / Enterprise Value 367.7m)
FCF Margin = 43.25% (FCF TTM 77.2m / Revenue TTM 178.5m)
Net Margin = 41.33% (Net Income TTM 73.8m / Revenue TTM 178.5m)
Gross Margin = 66.05% ((Revenue TTM 178.5m - Cost of Revenue TTM 60.6m) / Revenue TTM)
Gross Margin QoQ = 70.49% (prev 72.25%)
Tobins Q-Ratio = 0.14 (Enterprise Value 367.7m / Total Assets 2.56b)
Interest Expense / Debt = 5.94% (Interest Expense 68.5m / Debt 1.15b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 84.5m (EBIT 106.9m * (1 - 21.00%))
Current Ratio = 2.40 (Total Current Assets 1.61b / Total Current Liabilities 673.8m)
Debt / Equity = 1.17 (Debt 1.15b / totalStockholderEquity, last quarter 982.1m)
Debt / EBITDA = -2.93 (Net Debt -322.5m / EBITDA 110.1m)
Debt / FCF = -4.18 (Net Debt -322.5m / FCF TTM 77.2m)
Total Stockholder Equity = 990.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.89% (Net Income 73.8m / Total Assets 2.56b)
RoE = 7.45% (Net Income TTM 73.8m / Total Stockholder Equity 990.5m)
RoCE = 5.69% (EBIT 106.9m / Capital Employed (Equity 990.5m + L.T.Debt 887.1m))
RoIC = 3.31% (NOPAT 84.5m / Invested Capital 2.55b)
WACC = 5.64% (E(690.1m)/V(1.84b) * Re(7.22%) + D(1.15b)/V(1.84b) * Rd(5.94%) * (1-Tc(0.21)))
Discount Rate = 7.22% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 53.34 | Cagr: 0.40%
[DCF] Terminal Value 73.10% ; FCFF base≈84.2m ; Y1≈73.8m ; Y5≈59.7m
[DCF] Fair Price = 23.46 (EV 957.6m - Net Debt -322.5m = Equity 1.28b / Shares 54.6m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -74.54 | EPS CAGR: -4.87% | SUE: -0.35 | # QB: 0
Revenue Correlation: 34.51 | Revenue CAGR: 2.50% | SUE: -0.53 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.33 | Chg30d=-2.13% | Revisions=-50% | Analysts=8
EPS current Year (2026-12-31): EPS=1.31 | Chg30d=-1.26% | Revisions=-38% | GrowthEPS=-17.8% | GrowthRev=-10.3%
EPS next Year (2027-12-31): EPS=1.33 | Chg30d=-0.40% | Revisions=-38% | GrowthEPS=+1.6% | GrowthRev=+0.6%
[Analyst] Revisions Ratio: -56% (up=2, down=11)